TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel
11 avr. 2018 08h30 HE
|
TESARO, Inc.
Agreement covers all indications for ZEJULA, excluding prostate cancer ZUG, Switzerland and PETACH TIKVA, Israel, April 11, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an...